ABC01397CZ

Tofacitinib Impurity R

Tofacitinib Impurity R is a chlorinated aromatic sulfonamide derivative featuring a substituted pyrimidine core. Its structure incorporates a 4-chlorobenzyl moiety linked via an amide bond to a sulfonamide group, diverging from Tofacitinib by the absence of a terminal piperazine ring. This impurity arises during synthetic pathways involving chloro-substituted benzyl precursors, where incomplete alkylation or amidation steps yield the sulfonamide-substituted byproduct. It serves as a critical HPLC reference standard for quantifying process-related impurities in Tofacitinib active pharmaceutical ingredient batches.

On Request
Molecular Formula C13H10ClN3O2S
Molecular Weight 307.7600
CAS Number 479633-63-1 โœ“ Verified
PubChem CID 44228967 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Tofacitinib
Lead Time On Request
IUPAC Name 4-chloro-7-(4-methylphenyl)sulfonylpyrrolo[2,3-d]pyrimidine

๐Ÿ“ Synonyms

4-Chloro-7-(p-toluenesulfonyl)-7H-pyrrolo[2,3-d]pyrimidine 4-Chloro-7-(p-toluenesulfonyl)-7H-pyrrolo(2,3-d)pyrimidine RefChem:521664 811-000-2 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine 479633-63-1 MFCD09907939 4-chloro-7-(4-methylbenzenesulfonyl)-7H-pyrrolo[2,3-d]pyrimidine 7H-PYRROLO[2,3-D]PYRIMIDINE, 4-CHLORO-7-[(4-METHYLPHENYL)SULFONYL]- Tofacitinib Impurity 09

๐Ÿ”ฌ Chemical Identifiers

CC1=CC=C(C=C1)S(=O)(=O)N2C=CC3=C2N=CN=C3Cl
InChI=1S/C13H10ClN3O2S/c1-9-2-4-10(5-3-9)20(18,19)17-7-6-11-12(14)15-8-16-13(11)17/h2-8H,1H3
BTOJSYRZQZOMOK-UHFFFAOYSA-N

Related Products